Market revenue in 2023 | USD 129.8 million |
Market revenue in 2030 | USD 295.6 million |
Growth rate | 12.5% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 58.71% in 2023. Horizon Databook has segmented the UK microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
Sequencing technology is being used in clinical diagnostic laboratories in the UK for regular screening of inherited and pathogenic variants. For instance, Sheffield Children’s NHS Foundation Trust has been providing sequencing-based diagnostic services since 2013. The services are provided to the NHS, and they support local research projects qualitatively and cost-effectively in a CPA-accredited laboratory.
The NGS services offered cover 147 genes to detect hereditary cancers along with other disorders including microbiome-related disorders. The available hereditary cancer panels detect breast, ovarian, colorectal, and renal cancers. Moreover, rising growth of genomics in precision medicine and supportive government legislation pertaining to microbiome sequencing is projected to boost the country’s market.
For instance, in March 2023, Wellcome Sanger Institute and the UK Health Security Agency launched the respiratory virus and microbiome initiative. This initiative aimed to develop an early warning system for emerging viral threats and avoid future pandemics.
Horizon Databook provides a detailed overview of country-level data and insights on the UK microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into UK microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account